{"id":"tricyclamol-chloride","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"tricyclamol methochloride","offLabel":[],"synonyms":["tricyclamol chloride","tricyclamol methochloride","tricyclamol methyl chloride"],"timeline":[],"approvals":[],"brandName":"Tricyclamol Methochloride","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a city, and Tricyclamol Methochloride is a key that unlocks a specific door to change how the city works. However, since the target and mechanism of action are unknown, it's like trying to find the right key without knowing what door it unlocks. More research is needed to understand how it works and what it does.","oneSentence":"Tricyclamol Methochloride is a small molecule that works by interacting with specific biological molecules, but the exact mechanism is unknown.","technicalDetail":"Tricyclamol Methochloride is a small molecule that likely interacts with a specific protein or receptor to produce its therapeutic effects, but the exact molecular details are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2736","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TRICYCLAMOL CHLORIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T16:08:11.625815","biosimilars":[],"competitors":[],"genericName":"tricyclamol chloride","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"001733","UNII":"QYH21J350Z","CHEBI":"CHEBI:135284","INN_ID":"458","UMLSCUI":"C0770459","ChEMBL_ID":"CHEMBL2104544","PUBCHEM_CID":"72169"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tricyclamol Methochloride, also known as Tricyclamol Chloride, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules, but the exact mechanism is unknown. Further research is needed to understand its potential therapeutic applications and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}